16- CML Therapeutic Agents with Reduced Drug-Resistance and Side-effect Comprising 16-Disubstituted Indole Compounds
The present invention relates to a chronic myelogenous leukemia therapeutic agent with reduced drug resistance and side effects containing a 1,6-disubstituted indole compound. 본 발명은 1,6-이치환된 인돌 화합물을 함유하는 약물 내성 및 부작용이 저감된 만성골수성백혈병 치료제에 관한 것이다....
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to a chronic myelogenous leukemia therapeutic agent with reduced drug resistance and side effects containing a 1,6-disubstituted indole compound.
본 발명은 1,6-이치환된 인돌 화합물을 함유하는 약물 내성 및 부작용이 저감된 만성골수성백혈병 치료제에 관한 것이다. |
|---|